Sign in
Not yet taking people in United StatesNo phase

Following Patients With Skin Conditions Such as Vitiligo, Atopic Dermatitis and Alopecia Areata

Collects real-world treatment results from people with skin diseases and their doctors.

Key facts

Who runs it
Target PharmaSolutions, Inc.
Where
New York, United StatesSee the site
Trial code
Registry title
An Observational Study of Patients With Dermatologic Disease
Status
Not yet recruiting
People taking part
2,000,000 people, planned
Started
Sept 2026
Expected to end
3 Aug 2041
Type of study
Observational, 2 groups
Record updated
10 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults and children treated for a skin disease in the United States, or for doctors who treat these patients. It only collects data in usual care.

Age
Adults and children (no exact age range given in the record).
Sex
All sexes can join.
Disease stage
A diagnosis of dermatologic disease, based on an ICD code or another healthcare code in the health record.

Main reasons for not taking part

  • Participants who withdrew consent
  • People who do not complete the activities required for their cohort

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Adult or pediatric participants managed for DD invited to participate OR a provider who treats patients with these conditions. Informed consent is required for all Engaged Cohort participants
  • Adult or pediatric participants at the time of enrollment with a diagnosis of DD by ICD code or other relevant healthcare code as part of the EHR interface

Who cannot take part

  • Participant withdrew consent; Failure to complete activities as required per the cohort clarification letter

Where in United States

  • Greenwich Village DermatologyNew York, United StatesContact: Jasmina JeterNot yet recruiting

About the trial

What the trial wants to find out

TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatologic disease (DD) and providers who treat these patients. The study includes patients managed for DD of any etiology in usual clinical practice in the United States and addresses important clinical questions regarding the management of DD by collecting and analyzing data from patients at academic medical centers and community medical practices and/or data from providers who treat them.

The 2 groups in the trial

  • Disease Cohort

    Adult patients and patients under the age of majority with a diagnosis of DD by ICD or other relevant healthcare code in the EHR interface.

  • Engaged Cohort

    Adult patients and patients under the age of majority diagnosed and managed for DD invited to participate OR HCPs who treat patients with these conditions. * Informed consent is required for all participants in an Engaged Cohort. * Willing to complete required Engaged Cohort activities.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
An Observational Study of Patients With Dermatologic Disease
Plain-language title
Following Patients With Skin Conditions Such as Vitiligo, Atopic Dermatitis and Alopecia AreataGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Record updated
10 September 2026